Effect of surgical trauma on epithelial cell adhesion molecule (GA-733) vaccine-induced tumor resistance

I Kirman1, A Maydelman, Z Asi

  • 1Department of Surgery, College of Physicians and Surgeons of Columbia University, BB1716, 630 West 168th Street, New York, NY 10032, USA. ik139@columbia.edu

Surgical Endoscopy
|November 29, 2002
PubMed
Abstract

Insights

Surgical intervention impairs the immune response to the epithelial cell adhesion molecule (EpCAM) vaccine in colon cancer models. Open surgery significantly reduced antibody production, hindering vaccine efficacy against tumors.

Area of Science:

  • Immunology
  • Surgical Oncology
  • Vaccine Development

Background:

  • Surgical trauma is known to suppress immune function.
  • The study investigates the impact of surgery on immune response to epithelial cell adhesion molecule (EpCAM), a target for colon cancer vaccination.

Purpose of the Study:

  • To evaluate the effect of surgical intervention on the immune response to an EpCAM-based vaccine.
  • To determine if surgical methods influence the efficacy of EpCAM vaccination in colon cancer.

Main Methods:

  • Mice received a GA-733 (EpCAM) vaccine with monophosphoryl-lipid A (MPLA) via biodegradable beads.
  • Surgical groups included control, insufflation, and laparotomy.
  • Immune response was assessed by measuring anti-GA733 IgG antibodies and cytotoxic T-cell activity against EpCAM-expressing colon cancer cells.

Main Results:

  • The GA-733 vaccine reduced tumor size significantly only in control mice.
  • While all immunized groups showed a greater cytotoxic response than controls, anti-GA733 IgG levels increased significantly only in control and insufflation groups.
  • Laparotomy surgery led to a significant decrease in antibody response to the EpCAM vaccine.

Conclusions:

  • The GA-733 vaccine can reduce tumor growth and elicit specific immune responses.
  • Open surgery (laparotomy) diminishes the antibody-mediated immune response to the EpCAM vaccine.
  • Surgical management may compromise the effectiveness of EpCAM-targeted cancer vaccines.

Related Concept Videos

Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved in a...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...